Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
How modern monitoring paradigms impact CRA roles
A planning guide for health technology developers
Digital health technologies provide a roadmap for modernising clinical trials
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
6 November 2025. Register now.
18 November 2025. Register now.
ICON CARES is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
1:04:04
This webinar discusses how we can develop a methodology and minimum standards for migrating instruments that would be applicable to any device.
34:00
This webinar reviews the new European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR)
49:54
